Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 24% ± 6% | |
epithelial cell | 7 studies | 33% ± 15% | |
ciliated cell | 7 studies | 26% ± 9% | |
B cell | 6 studies | 19% ± 6% | |
macrophage | 6 studies | 24% ± 4% | |
classical monocyte | 5 studies | 24% ± 10% | |
glutamatergic neuron | 5 studies | 34% ± 16% | |
oligodendrocyte | 5 studies | 23% ± 4% | |
non-classical monocyte | 4 studies | 28% ± 6% | |
hematopoietic precursor cell | 4 studies | 22% ± 2% | |
fibroblast | 4 studies | 20% ± 5% | |
dendritic cell | 4 studies | 28% ± 11% | |
plasmacytoid dendritic cell | 4 studies | 24% ± 7% | |
conventional dendritic cell | 3 studies | 37% ± 13% | |
lymphocyte | 3 studies | 19% ± 4% | |
type I pneumocyte | 3 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 36% ± 7% | |
microglial cell | 3 studies | 23% ± 5% | |
abnormal cell | 3 studies | 23% ± 5% | |
monocyte | 3 studies | 18% ± 2% | |
intestinal crypt stem cell | 3 studies | 17% ± 2% | |
basal cell | 3 studies | 31% ± 3% | |
transit amplifying cell | 3 studies | 27% ± 10% | |
goblet cell | 3 studies | 18% ± 2% | |
neuron | 3 studies | 32% ± 12% | |
natural killer cell | 3 studies | 20% ± 4% | |
astrocyte | 3 studies | 21% ± 2% | |
interneuron | 3 studies | 29% ± 12% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 4316.24 | 21 / 21 | 100% | 54.46 | 504 / 504 |
brain | 100% | 5888.23 | 2642 / 2642 | 100% | 113.91 | 705 / 705 |
esophagus | 100% | 4095.45 | 1445 / 1445 | 100% | 44.05 | 183 / 183 |
intestine | 100% | 4965.72 | 966 / 966 | 100% | 52.25 | 527 / 527 |
kidney | 100% | 4177.27 | 89 / 89 | 100% | 44.46 | 901 / 901 |
liver | 100% | 2312.92 | 226 / 226 | 100% | 30.11 | 406 / 406 |
ovary | 100% | 4103.68 | 180 / 180 | 100% | 45.73 | 430 / 430 |
prostate | 100% | 5318.60 | 245 / 245 | 100% | 43.43 | 502 / 502 |
stomach | 100% | 3490.13 | 359 / 359 | 100% | 45.88 | 286 / 286 |
thymus | 100% | 5182.25 | 653 / 653 | 100% | 57.79 | 605 / 605 |
uterus | 100% | 4356.61 | 170 / 170 | 100% | 56.49 | 459 / 459 |
lung | 100% | 4340.79 | 578 / 578 | 100% | 49.56 | 1154 / 1155 |
breast | 100% | 4195.99 | 459 / 459 | 100% | 53.30 | 1117 / 1118 |
skin | 100% | 4527.69 | 1809 / 1809 | 100% | 48.22 | 471 / 472 |
pancreas | 100% | 2204.24 | 327 / 328 | 100% | 49.16 | 178 / 178 |
adrenal gland | 100% | 3579.27 | 258 / 258 | 100% | 49.86 | 229 / 230 |
adipose | 100% | 3695.61 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 76.65 | 29 / 29 |
spleen | 100% | 6869.16 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 47.83 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 37.70 | 1 / 1 |
blood vessel | 100% | 3760.17 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2730.93 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2831.51 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 4905.05 | 919 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 45.54 | 79 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_1901799 | Biological process | negative regulation of proteasomal protein catabolic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | PSME3IP1 |
Protein name | Proteasome activator subunit 3 interacting protein 1 NIP30 protein (Proteasome activator subunit 3 interacting protein 1) PSME3-interacting protein (NEFA-interacting nuclear protein NIP30) (PA28G-interacting protein) |
Synonyms | CDA10 CDA018 PIP30 C16orf94 NIP30 FAM192A |
Description | FUNCTION: Promotes the association of the proteasome activator complex subunit PSME3 with the 20S proteasome and regulates its activity. Inhibits PSME3-mediated degradation of some proteasome substrates, probably by affecting their diffusion rate into the catalytic chamber of the proteasome. Also inhibits the interaction of PSME3 with COIL, inhibits accumulation of PSME3 in Cajal bodies and positively regulates the number of Cajal bodies in the nucleus. . |
Accessions | ENST00000566403.5 H3BUL4 ENST00000569266.5 ENST00000568671.5 Q6P4H7 H3BTP8 ENST00000565760.5 ENST00000309137.13 ENST00000570184.1 ENST00000564424.1 ENST00000566681.1 H3BSY6 H3BTI2 H3BMX9 H3BP64 ENST00000565458.5 H3BN22 H3BQQ6 H3BU93 H3BSF0 ENST00000566481.5 ENST00000562324.5 H3BNK9 Q9GZU8 ENST00000562406.5 ENST00000565956.5 ENST00000567044.5 ENST00000566584.5 H3BPF9 ENST00000567439.5 ENST00000566077.5 H3BPH9 ENST00000564108.5 |